STERIS plc (STE)

Market Cap	21.40B -3.4%
Revenue (ttm)	5.83B +8.0%
Net Income	707.74M +51.3%
EPS	7.16 +51.8%
Shares Out	98.08M
PE Ratio	30.52
Forward PE	20.23
Dividend	$2.52 (1.15%)
Ex-Dividend Date	Feb 17, 2026

Volume	95,657
Open	219.18
Previous Close	219.97
Day's Range	217.92 - 220.40
52-Week Range	204.90 - 269.44
Beta	1.07
Analysts	Buy
Price Target	275.20 (+26.09%)
Earnings Date	May 13, 2026

About STE

STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in procedure rooms, including surgical tables, lights, and ...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Jun 1, 1992
• Employees: 17,787
• Stock Exchange: NYSE
• Ticker Symbol: STE
• Website: https://www.steris.com

Financial Performance

In fiscal year 2025, STERIS's revenue was $5.46 billion, an increase of 6.24% compared to the previous year's $5.14 billion. Earnings were $614.64 million, an increase of 62.50%.

Analyst Summary

According to 6 analysts, the average rating for STE stock is "Buy." The 12-month stock price target is $275.2, which is an increase of 26.09% from the latest price.

Price Target

$275.2

(26.09% upside)

Analyst Consensus: Buy